🌟 HOPE FOR THE WEEK: Explore the pioneering Bridge to HOPE Trial findings presented at ATC: https://ow.ly/HkCJ50Sr0nL Analysis from the trial demonstrated reductions in EAD and enhanced clinical outcomes with HOPE compared to standard cold storage. #ATC2024Philly #EAD #HOPEvsSCS #HOPEForTheWeek
Bridge to Life Ltd.’s Post
More Relevant Posts
-
Join us at the upcoming Joint Statistics Meeting on August 6, 2024, where our very own Tyson Rogers from NAMSA will be showcasing his expertise. Don't miss out on his poster presentation titled "Effective Use of Simulation and Resampling Methods for Medical Device Studies." 📊 Dive into the world of advanced statistics with Tyson as he unravels the complexities of simulation and resampling methods, demonstrating their crucial role in medical device research. 🕥 Set your reminders for 10:30 AM - 12:20 PM to catch this insightful session. It's a golden opportunity to learn from one of the best and enhance your understanding of statistical applications in the medical field. See you there! #JSM2024 #Statistics #MedicalDevices #ResamplingMethods #NAMSA
To view or add a comment, sign in
-
Here's a quick snap of where you can find Carlos E. Orantes, Chair of hyperCORE and CEO at Alcanza Clinical Research during the Society for Clinical Research Sites (SCRS) Global Site Summit in just two weeks! Will we see *you* in Hollywood? 😎 Stop by our Booth #618 if you'll be there! #researchaccelerated #clinicaltrials #clinicalresearch #hypercoreint #scrs
To view or add a comment, sign in
-
SESAM 2024 - Here are some things we would like to talk about: ➟ Why isn't diversity 'nomal' in medical simulation? ➟ How partners could help us distribute R42 in Europe. ➟ Finding smaller, more innovative medical simulation companies. ➟ The latest debrief innovations in simulation. Are you going to be there? Let us know! Not going to be at SESAM? Talk to us at [email protected] SESAM - Society for Simulation in Europe #SESAM #SSESAM2024 #medicalsimulation #healthcare #bariatricmedicine
To view or add a comment, sign in
-
Want to know more about treating patients beyond ESA failure in patients with LR-#MDS? 🔬🩸 Valeria Santini from Università degli Studi di Firenze tells us more 🎥 Check out our interview with her within our NEW FEATURE: 'Spotlight on Lower-risk #MDS' The first in a practical educational series 💡 👉 https://lnkd.in/dqF2SfPC #HemOnc #MDSsm
To view or add a comment, sign in
-
Enhance. Combine. Unify. With one word: Integration. From precise trajectory planning to lead verification and orientation visualization, we're here to optimize your DBS clinical practice. Don't miss the chance to discover more at our booth #2 with Brainlab at #ESSFN2023. #BSCEMEA #DeepBrainStimulation #Parkinson
To view or add a comment, sign in
-
Innovator | Strategist | Advisor | Consultant | Board Member | Clinical Executive | Regulatory Affairs | Clinical Affairs | Scientific Affairs
Colleagues and friends, are you going to SCOPE 2024? We look forward to meeting you there and sharing with you the new developments of the IEEE-SA, Clinical Trial Technology Modernization Network (CTTMN). February 13, 2024, 9:30 AM - 9:45 AM EST CO-PRESENTATION: Creating a Framework for Excellence: Technology and Global Standards in Decentralized Clinical Trials. Presenters on behalf of the IEEE-SA, Clinical Trial Technology Modernization Network (CTTMN): Mathew Rose, MD MS Isaac R. Rodriguez-Chavez, PhD, MHSc, MSc Link to the agenda: https://lnkd.in/enExyNM3 #DCTs #decentralizedclinicaltrials #decentralizedtrials #dhts #digitalmedicine #clinicalresearch #clinicaltrials #clinicalstudies #digitalhealthcare #digitalhealth
To view or add a comment, sign in
-
This is optimal.
#TED2024 "TED Talk": We are thrilled that Alex Luebke and Vivek Kumbhari MD PhD will present at #TED2024! Join us for this innovative "Medical Micro-Robots" TED Talk on Tuesday, April 16, 8:45-10:30A at #TED2024 "The Brave and The Brilliant"! tedtalks.social/3xtXo6
To view or add a comment, sign in
-
📆 Upcoming ASCPT Webinar | Join Sarthak Chatterjee, Ph.D., Grace Lee, Martijn Muller and Jie Ren for Toward Algorithmic Literacy for Digital Measures: Increasing Interpretability and Comprehension of Gait Feature Extraction Algorithms, Sept. 27, 10 a.m. ET. Advances in data processing algorithms and increasing access to tools for data collection are changing the way clinical trials are conducted. While these technologies can provide us with powerful insights into disease progression, it is critical that researchers and regulators are well-informed on the potential shortcomings or nuances regarding these algorithms. In this webinar, we delve into how algorithmic literacy— a framework for comprehending algorithms in their specific use cases in drug development— can help demystify the behavior of these algorithms, using gait analysis in Parkinson's Disease as an example use case. Registration and full details, here: https://lnkd.in/gT7n7UvU #CPath #ASCPT #digitalmeasures #webinar #globalhealth #collaboration #datasharing #drugdevelopment
To view or add a comment, sign in
-
Dr. Jieli Shirley Li discusses the advantages and challenges of standardization in clinical laboratory services across a large healthcare system in our latest PACE-accredited Lab Briefings webinar, available at no cost to you. Watch the recording and learn more about our continuing education offerings here: #lab #pace #labCE
To view or add a comment, sign in
-
Dr. Jieli Shirley Li discusses the advantages and challenges of standardization in clinical laboratory services across a large healthcare system in our latest PACE-accredited Lab Briefings webinar, available at no cost to you. Watch the recording and learn more about our continuing education offerings here: #lab #pace #labCE
To view or add a comment, sign in
3,174 followers
MD,FACS,FEBS (TRANSPLANT) Ass.Prof ( UPV-EHU) en Hospital Universitario Cruces - OSI Ezkerraldea Enkarterri Cruces
3wCongrats for the OC.But for me there are many incognities and to much deduction.You can see that with SCS vs HOPE there are more EAD.Beeing in for sub analysis the DCD one of the most important issues.We don’t know which technique toy use.And with this in my opinnion you can’t make those take home messages as there are very important vías in this studies.